Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2017 3
2018 4
2019 4
2020 2
2021 8
2022 3
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Factors associated with dimethyl fumarate-induced lymphopenia.
Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM. Sainz de la Maza S, et al. Among authors: villarrubia n. J Neurol Sci. 2019 Mar 15;398:4-8. doi: 10.1016/j.jns.2019.01.007. Epub 2019 Jan 8. J Neurol Sci. 2019. PMID: 30658226
Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients.
Domínguez-Mozo MI, García-Frontini Nieto MC, Gómez-Calcerrada MI, Pérez-Pérez S, García-Martínez MÁ, Villar LM, Villarrubia N, Costa-Frossard L, Arroyo R, Alvarez-Lafuente R. Domínguez-Mozo MI, et al. Among authors: villarrubia n. Biology (Basel). 2022 Nov 8;11(11):1633. doi: 10.3390/biology11111633. Biology (Basel). 2022. PMID: 36358334 Free PMC article.
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: villarrubia n. Front Immunol. 2022 Mar 21;13:842354. doi: 10.3389/fimmu.2022.842354. eCollection 2022. Front Immunol. 2022. PMID: 35386690 Free PMC article.
Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.
Pérez-Pérez S, Domínguez-Mozo MI, García-Martínez MÁ, García-Frontini MC, Villarrubia N, Costa-Frossard L, Villar LM, Arroyo R, Álvarez-Lafuente R. Pérez-Pérez S, et al. Among authors: villarrubia n. Front Immunol. 2021 Nov 29;12:798003. doi: 10.3389/fimmu.2021.798003. eCollection 2021. Front Immunol. 2021. PMID: 34912348 Free PMC article.
Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE. Moreira A, et al. Among authors: villarrubia n. Front Immunol. 2019 Oct 15;10:2403. doi: 10.3389/fimmu.2019.02403. eCollection 2019. Front Immunol. 2019. PMID: 31681293 Free PMC article. Clinical Trial.
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55-IL6ST Gene Region in Immature Dendritic Cells.
Mena J, Alloza I, Tulloch Navarro R, Aldekoa A, Díez García J, Villanueva Etxebarria A, Lindskog C, Antigüedad A, Boyero S, Mendibe-Bilbao MDM, Álvarez de Arcaya A, Sánchez Menoyo JL, Midaglia L, Villarrubia N, Malhotra S, Montalban X, Villar LM, Comabella M, Vandenbroeck K. Mena J, et al. Among authors: villarrubia n. Front Immunol. 2022 Jan 17;12:816930. doi: 10.3389/fimmu.2021.816930. eCollection 2021. Front Immunol. 2022. PMID: 35111166 Free PMC article.
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.
Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: villarrubia n. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 6;8(2):e940. doi: 10.1212/NXI.0000000000000940. Print 2021 Mar 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33408167 Free PMC article.
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab.
Walo-Delgado PE, Monreal E, Medina S, Quintana E, Sainz de la Maza S, Fernández-Velasco JI, Lapuente P, Comabella M, Ramió-Torrentà L, Montalban X, Midaglia L, Villarrubia N, Carrasco-Sayalero A, Rodríguez-Martín E, Roldán E, Meca-Lallana J, Alvarez-Lafuente R, Masjuan J, Costa-Frossard L, Villar LM. Walo-Delgado PE, et al. Among authors: villarrubia n. Front Immunol. 2021 Oct 8;12:760546. doi: 10.3389/fimmu.2021.760546. eCollection 2021. Front Immunol. 2021. PMID: 34691084 Free PMC article. Clinical Trial.
Acetate correlates with disability and immune response in multiple sclerosis.
Pérez-Pérez S, Domínguez-Mozo MI, Alonso-Gómez A, Medina S, Villarrubia N, Fernández-Velasco JI, García-Martínez MÁ, García-Calvo E, Estévez H, Costa-Frossard L, Alvarez-Cermeño JC, Luque-Garcia JL, Arroyo R, Villar LM, Alvarez-Lafuente R. Pérez-Pérez S, et al. Among authors: villarrubia n. PeerJ. 2020 Nov 16;8:e10220. doi: 10.7717/peerj.10220. eCollection 2020. PeerJ. 2020. PMID: 33240608 Free PMC article.
23 results